文献速递骨肌MR

软组织肿瘤报告与数据系统(ST-RADS):前瞻性实施与诊断准确性

Soft-Tissue Tumor Reporting and Data System (ST-RADS): Prospective implementation and diagnostic accuracy.
PubMed 文献 · Clin Radiol · 2025-12-16

在三级医疗中心前瞻性实施ST-RADS后,对236例连续软组织肿瘤MRI患者进行审计,比较ST-RADS评分与传统描述报告的诊断准确性。ST-RADS总体准确率99.15% vs 传统描述92.80%(p=0.000),活检 confirmed 病例中97.73% vs 82.95%(p=0.00098),良性肿瘤中100% vs 93.75%(p=0.003),恶性肿瘤中96.74% vs 89.13%(p=0.109,未达统计学显著)。

要点

  • ST-RADS评分总体诊断准确率99.15%,显著高于传统描述报告的92.80%。
  • 活检 confirmed 病例中ST-RADS准确率97.73%,传统描述为82.95%。
  • 良性肿瘤(ST-RADS I-III)ST-RADS准确率100%,传统描述为93.75%。

核心结论

  • 前瞻性应用ST-RADS评分系统的诊断准确率显著优于传统描述方法,结果支持在临床实践中更广泛地实施ST-RADS,作为肌肉骨骼软组织肿瘤分类的标准化方法,提供标准化管理建议并纵向收集数据以追踪患者结局。

研究设计与样本

  • IRB批准的审计研究,前瞻性在电子口述系统中实施ST-RADS后,由接受 fellowship 培训的肌肉骨骼放射科医师对软组织肿瘤及肿瘤样病变进行常规分类;纳入2023年1月至2024年5月期间在三级医疗中心连续接受MRI检查的236例患者;收集人口统计学、影像表现、病变特征、活检结果、治疗及临床结局数据;使用McNemar检验比较ST-RADS与描述性报告的诊断准确性。

诊断标准与关键数值

  • ST-RADS分布:I级2.12%、II级36.86%、III级22.03%、IV级5.93%、V级4.24%、VI级28.81%;总体诊断准确率ST-RADS 99.15% vs 描述性报告92.80%(p=0.000);活检 confirmed 病例中ST-RADS 97.73% vs 描述性报告82.95%(p=0.00098);良性肿瘤(ST-RADS I-III)ST-RADS 100% vs 描述性报告93.75%(p=0.003);恶性肿瘤(ST-RADS IV-VI)ST-RADS 96.74% vs 描述性报告89.13%(p=0.109,差异未达统计学显著)。

临床应用与阅片要点

  • 作者主张在临床实践中更广泛地实施ST-RADS,作为肌肉骨骼软组织肿瘤分类的标准化方法,提供标准化管理建议并纵向收集数据以追踪患者结局。

局限性

  • 恶性肿瘤(ST-RADS IV-VI)中ST-RADS与描述性报告的准确率差异未达统计学显著(p=0.109)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To assess clinical performance with prospective implementation of the ST-RADS scoring and compare it to traditional descriptions.

MATERIALS AND METHODS: Following prospective implementation of ST-RADS in the electronic dictation system, fellowship-trained musculoskeletal radiologists classified soft tissue tumors and tumor-like lesions routinely. This IRB-approved audit study included 236 consecutive patients with MRIs from 01/2023 to 05/2024 at a tertiary care center. Data on patient demographics, imaging findings, lesion characteristics, biopsy results, treatments, and clinical outcomes were collected. Diagnostic accuracy of ST-RADS versus descriptive reporting was compared using McNemar test.

RESULTS: The cohort (mean age: 54.3 years; 61.02 % female) had both lower extremity (47.03 %) and upper extremity (37.29 %) masses. The distribution included ST-RADS I (2.12 %), ST-RADS II (36.86 %), ST-RADS III (22.03 %), ST-RADS IV (5.93 %), ST-RADS V (4.24 %), and ST-RADS VI (28.81 %). ST-RADS demonstrated superior diagnostic accuracy compared to descriptive reporting overall (99.15 % vs. 92.80 %, p=0.000) and also within biopsy-confirmed cases (97.73 % vs. 82.95 %, p=0.00098). For benign tumors (ST-RADS I-III), ST-RADS achieved 100 % accuracy compared to 93.75 % for descriptive reporting (p=0.003). For malignant tumors (ST-RADS IV-VI), ST-RADS also showed higher accuracy compared to descriptive reporting (96.74 % vs. 89.13 %), although difference did not reach statistical significance (p=0.109).

CONCLUSIONS: Prospective application of the ST-RADS scoring system demonstrated significantly superior accuracy compared to traditional descriptive methods. These results advocate for broader implementation of ST-RADS in clinical practice as a standardized method for classifying musculoskeletal soft tissue tumors, providing standardized management recommendations, and longitudinal data collection for tracking patient outcomes.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Zhu A, Mesarick E, Mian Y, et al. Soft-Tissue Tumor Reporting and Data System (ST-RADS): Prospective implementation and diagnostic accuracy. Clin Radiol. 2025. PMID: 41570640. doi:10.1016/j.crad.2025.107216

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。